Literature DB >> 20215749

Treatment effects of therapeutic cholinesterase inhibitors on visuospatial processing in Alzheimer's disease: a longitudinal functional MRI study.

Subha N Thiyagesh1, Tom F D Farrow, Randolph W Parks, Hector Accosta-Mesa, Michael D Hunter, Claire Young, Iain D Wilkinson, Peter W R Woodruff.   

Abstract

BACKGROUND/AIMS: Visuospatial impairments are known to occur in Alzheimer's disease (AD). We hypothesised that functional magnetic resonance imaging (fMRI) response in task-related brain regions would be impaired in patients with AD during the task and that treatment with acetyl cholinesterase inhibitors would enhance activations in brain regions concerned with this visual perceptual processing.
METHOD: Ten AD subjects were neuropsychologically assessed and underwent fMRI imaging whilst performing a series of visuospatial perception tasks, before and after treatment with acetyl cholinesterase inhibitors. Eleven healthy elderly comparison subjects were also scanned twice.
RESULTS: Regions of increased brain activation in AD included the left precuneus, left cuneus, left supramarginal gyrus, right parieto-temporal cortex and right inferior parietal lobule. Further, increased activation in the left precuneus was found to correlate significantly with improved functioning of activities of daily living.
CONCLUSIONS: We believe this to be the first fMRI study that, after controlling for the confound of repeat scanning, demonstrates altered patterns of brain activation associated with visuospatial processing following treatment in patients with AD. The treatment-related improvement of visual perception in AD may rely on enhanced attentional mechanisms, thereby possibly supporting independent living through improvement on activities of daily living.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215749     DOI: 10.1159/000275674

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  8 in total

1.  Evidence of altered corticomotor system connectivity in early-stage Alzheimer's disease.

Authors:  Eric D Vidoni; George P Thomas; Robyn A Honea; Natalia Loskutova; Jeffrey M Burns
Journal:  J Neurol Phys Ther       Date:  2012-03       Impact factor: 3.649

Review 2.  Toward systems neuroscience in mild cognitive impairment and Alzheimer's disease: a meta-analysis of 75 fMRI studies.

Authors:  Hui-Jie Li; Xiao-Hui Hou; Han-Hui Liu; Chun-Lin Yue; Yong He; Xi-Nian Zuo
Journal:  Hum Brain Mapp       Date:  2014-11-19       Impact factor: 5.038

3.  Understanding the Pathophysiology of Alzheimer's Disease and Mild Cognitive Impairment: A Mini Review on fMRI and ERP Studies.

Authors:  Takao Yamasaki; Hiroyuki Muranaka; Yumiko Kaseda; Yasuyo Mimori; Shozo Tobimatsu
Journal:  Neurol Res Int       Date:  2011-07-07

4.  Functional neuroanatomy of spatial sound processing in Alzheimer's disease.

Authors:  Hannah L Golden; Jennifer L Agustus; Jennifer M Nicholas; Jonathan M Schott; Sebastian J Crutch; Laura Mancini; Jason D Warren
Journal:  Neurobiol Aging       Date:  2015-12-19       Impact factor: 4.673

5.  Cholinergic Enhancement of Brain Activation in Mild Cognitive Impairment during Episodic Memory Encoding.

Authors:  Shannon L Risacher; Yang Wang; Heather A Wishart; Laura A Rabin; Laura A Flashman; Brenna C McDonald; John D West; Robert B Santulli; Andrew J Saykin
Journal:  Front Psychiatry       Date:  2013-09-17       Impact factor: 4.157

6.  An Investigation of the Late Excitatory Potentials in the Hand following Transcranial Magnetic Stimulation in Early Alzheimer's Disease.

Authors:  Christina Balla; Alain Maertens de Noordhout; Jean Louis Pepin
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-11-21

7.  Beta-Band Functional Connectivity is Reorganized in Mild Cognitive Impairment after Combined Computerized Physical and Cognitive Training.

Authors:  Manousos A Klados; Charis Styliadis; Christos A Frantzidis; Evangelos Paraskevopoulos; Panagiotis D Bamidis
Journal:  Front Neurosci       Date:  2016-02-29       Impact factor: 4.677

Review 8.  Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment: a critical review.

Authors:  Elisa Canu; Elisabetta Sarasso; Massimo Filippi; Federica Agosta
Journal:  Alzheimers Res Ther       Date:  2018-02-20       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.